Population-Based Outcome Data of Extremely Preterm Infants in Germany during 2010-2017

Neonatology. 2022;119(3):370-376. doi: 10.1159/000524455. Epub 2022 Apr 29.

Abstract

Background and objective: Results of five randomized controlled trials (RCT) sequentially published in 2010-2013 suggested that aiming for higher, as opposed to lower oxygen saturation targets, reduces rates of mortality in infants <28 weeks of gestation, while increasing rates of severe retinopathy of prematurity (ROP). Two further RCTs published in 2011 and 2015 demonstrated that avoiding endotracheal intubation by minimally invasive surfactant administration reduces respiratory morbidity. Assuming that such data are likely to affect clinical practice and ultimate outcome, we analyzed population-level results in extremely preterm infants born across Germany during 2010-2017.

Methods: We used mandatory German quality surveillance data to compare mortality and morbidities in preterm infants born between 24 weeks 0 days and 27 weeks 6 days of gestation in 2010-2013 versus 2014-2017.

Results: Mortality decreased from 15.1% (1,366/9,058) in 2010-2013 to 12.7% (1,385/10,924) in 2014-2017, risk ratio (RR) 0.845 (95% confidence interval [CI], 0.784-0.901). Rates of severe ROP (≥grade 3) per survivor increased from 12.1% (930/7,692) to 13.3% (1.269/9,539), RR 1.100 (95% CI: 1.017-1.191). The lowest mortality and highest ROP rates were found in infants born in 2014. There was no change in rates of necrotizing enterocolitis, while those of bronchopulmonary dysplasia (BPD) decreased steadily between 2010 and 2017, alongside the increased proportion of infants who were never intubated.

Conclusions: There was a moderate decline in mortality, an insignificant increase in severe ROP, and a steady decline of BPD in Germany during 2010-2017. Avoiding endotracheal intubation may have contributed to lowered BPD rates.

Keywords: Bronchopulmonary dysplasia; Extreme prematurity; Mortality; Retinopathy of prematurity.

MeSH terms

  • Bronchopulmonary Dysplasia* / epidemiology
  • Child
  • Enterocolitis, Necrotizing* / epidemiology
  • Humans
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Pulmonary Surfactants* / therapeutic use
  • Retinopathy of Prematurity* / epidemiology

Substances

  • Pulmonary Surfactants